These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7272422)

  • 1. A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment.
    Koziol JA; Maxwell DA; Fukushima M; Colmerauer ME; Pilch YH
    Biometrics; 1981 Jun; 37(2):383-90. PubMed ID: 7272422
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
    Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
    Rodolfo M; Zilocchi C; Melani C; Cappetti B; Arioli I; Parmiani G; Colombo MP
    J Immunol; 1996 Dec; 157(12):5536-42. PubMed ID: 8955204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.
    Saffran DC; Horton HM; Yankauckas MA; Anderson D; Barnhart KM; Abai AM; Hobart P; Manthorpe M; Norman JA; Parker SE
    Cancer Gene Ther; 1998; 5(5):321-30. PubMed ID: 9824052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.
    Kim HA; Ko HM; Ju HW; Kim KJ; Roh SG; Lee HK; Im SY
    Cancer Lett; 2009 Feb; 274(1):160-4. PubMed ID: 18952369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intact tumor tissue in nude mice.
    Furukawa T; Kubota T; Watanabe M; Kuo TH; Kase S; Saikawa Y; Tanino H; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1993; 13(2):287-91. PubMed ID: 8517641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
    Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
    Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas.
    Melero I; Duarte M; Ruiz J; Sangro B; Galofré J; Mazzolini G; Bustos M; Qian C; Prieto J
    Gene Ther; 1999 Oct; 6(10):1779-84. PubMed ID: 10516729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.
    Sobotkova E; Duskova M; Tachezy R; Petrackova M; Vonka V
    Oncol Rep; 2009 Mar; 21(3):793-9. PubMed ID: 19212641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distribution-free test for paired growth curve analyses with application to an animal tumour immunotherapy experiment.
    Koziol JA; Maxwell DA
    Stat Med; 1982; 1(1):83-9. PubMed ID: 7187085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis.
    Xiong Z; Gharagozlou S; Vengco I; Chen W; Ohlfest JR
    Clin Cancer Res; 2008 Sep; 14(17):5484-93. PubMed ID: 18765540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors.
    Chiarella P; Vulcano M; Bruzzo J; Vermeulen M; Vanzulli S; Maglioco A; Camerano G; Palacios V; Fernández G; Brando RF; Isturiz MA; Dran GI; Bustuoabad OD; Ruggiero RA
    Cancer Immunol Immunother; 2008 May; 57(5):701-18. PubMed ID: 17962945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.
    Mazzolini G; Narvaiza I; Martinez-Cruz LA; Arina A; Barajas M; Galofré JC; Qian C; Mato JM; Prieto J; Melero I
    Gene Ther; 2003 Jul; 10(13):1067-78. PubMed ID: 12808437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes.
    Miyata T; Yamamoto S; Sakamoto K; Morishita R; Kaneda Y
    Cancer Gene Ther; 2001 Nov; 8(11):852-60. PubMed ID: 11773975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following "suicide" gene therapy in a murine colon carcinoma model.
    Alsheikhly AR; Zweiri J; Walmesley AJ; Watson AJ; Christmas SE
    Cancer Immunol Immunother; 2004 Nov; 53(11):946-54. PubMed ID: 15185012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.